Definitive Contract 75N95019C00033

Award Date 7/1/19
Potential Completion Date 6/30/20
Potential Value $606K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract HHSN271201400042C, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Johns Hopkins Bayview Medical Center, Inc. (Johns Hopkins Bayview) is for the provision of CLINICAL SUPPORT SERVICES AND RESOURCES. This is a Cost Plus Fixed Fee definitive contract with a potential value of $5,027,325.87 and a period of performance from July 29, 2014 to June 30, 2019. The contract was not set aside for any...
This is a $2,036,522.37 definitive cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University to provide clinical services and resources for NIDA's Intramural Research Program (IRP) in Baltimore, Maryland. The contract has a base period of six months and nine six-month option periods, running through June 2025. The contract was awarded on July 1, 2020 and does not have a set-aside...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to The Johns Hopkins University. The contract has a ceiling value of $107,615.73 and a completion date of May 10, 2018. The Johns Hopkins University, a private research university located in Baltimore, Maryland, is the prime contractor for this award. This contract does not have a set-aside designation. Based on the...
This is a $114,800 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University, a private research university in Baltimore, MD. The contract has an ultimate completion date of September 29, 2016 and was awarded on September 28, 2015. This contract was not set aside for any specific business type. The Johns Hopkins University has a strong track record of providing research,...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,007.40 firm fixed price purchase order contract to The Johns Hopkins University, a private non-profit university located in Baltimore, Maryland. The contract has no set-aside designation and was awarded on September 7, 2018 with a completion date of January 10, 2020. As a leading research institution, The Johns Hopkins University has a history of providing the U.S. government...
This is a $126,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to The Johns Hopkins University in Baltimore, Maryland. The contract is for JHMI DEEP SEQUENCING AND MICROARRAY CORE services and has an ultimate completion date of December 31, 2017. The award was made on September 23, 2016 and does not utilize a set-aside. The Johns Hopkins University is a private...
This is a $1,292,528.45 cost-no-fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to The Johns Hopkins University. The contract is for the NIH Pain Consortium - Centers of Excellence in Pain Education program, which aims to enhance pain management education for health care professionals. The contract has a period of performance from September 15, 2015 to September 14, 2019, with a one-year base period and several...
This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS), to Johns Hopkins Health System Corporation, doing business as Johns Hopkins Medicine, a non-profit healthcare organization based in Baltimore, Maryland. The contract is for parking services at the Johns Hopkins Bayview Medical Campus to support the National Institute on Aging (NIA) Intramural Research Program. The...
The National Institutes of Health's National Institute on Drug Abuse awarded a $32,720 purchase order to The Johns Hopkins University for gene sequencing and profiling of sample tissue. This firm fixed price contract supports the NIH/NIDA's biomedical research efforts through Johns Hopkins' delivery of genomic analysis services. No subcontractors or set aside designations were identified. The one year period of performance begins in July 2023, with work conducted at Johns Hopkins' Bethesda,...
This is a definitive cost-no-fee contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University to conduct testing of pharmacological interventions on rhesus monkeys. The $93,307.00 contract has a period of performance through March 31, 2015. The contract does not have a set-aside designation. As a leading research university, The Johns Hopkins University has a long history of supporting federal agencies...

This is a federal contract award by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Johns Hopkins Bayview Medical Center, Inc. The $606,213.21 Cost Plus Fixed Fee contract is for the provision of clinical services and resources in support of NIDA's Intramural Research Program (IRP) for the period of July 1, 2019 to June 30, 2020. The contract was not set aside for any specific business category. Johns Hopkins Bayview Medical Center, Inc. is a hospital and non-profit organization that is part of the Johns Hopkins Health System Corporation, a leading institution in biomedical discovery, healthcare transformation, and medical education.

Generated 6/21/24, 9:20 AM